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Background
A relationship between thyroid status and Alzheimer's dis-
ease (AD) has long been considered. Increasing evidence
also supports an extensive inter- relationship between thy-
roid hormones and the cholinergic system which is selec-
tively and early affected in AD. Cholinesterase inhibitors
(ChEIs) are the current treatment (Rx) of choice for these
patients. The aim of the present study was to explore the
possibility of an interplay between the acetyl cholineste-
rase inhibitor (AChEI) donezepil and thyroid function in
patients with AD.
Materials and methods
Thyroid function tests (TFTs) were evaluated in 28
patients (9 men and 19 women; mean age 74 ± 7.2 SD
years), suffering from AD before and after four months on
donepezil treatment. Serum thyrotropin (TSH), trio-
dothyronine (T3), thyroxine (T4), and the free fractions
(fT4 and fT3) as whell as thyroid autoantibodies (anti-
TPO, anti-Tg) were determined using standard methods.
Results
Significant reductions in T4, fT3, fT4 and anti TPO levels
were observed post-treatment, with a corresponding slight
increase of TSH. For of T4 and fT4 the reduction was exclu-
sively derived from the responders to the donezepil treat-
ment as compared to non-responders. Responders in
general presented with higher serum concentration of T4
and fT4 (all within the normal range of variation). Serum
levels in nonresponders remained unchanged.
Discussion
Relatively higher serum concentration of T4 and fT4 fol-
lowed by a post treatment decrease, may predict a favora-
ble response to donezepil treatment. As thyroid
hormones have been used to augment antidepressant
effectiveness in refractory depression, the question arises
as to weather small doses of T4 or T3 would have a possi-
ble beneficial effect in AD as well.
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